• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC CRYOCATH LP ARCTIC FRONT ADVANCE PRO¿ CARDIAC CRYOABLATION CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC CRYOCATH LP ARCTIC FRONT ADVANCE PRO¿ CARDIAC CRYOABLATION CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Model Number AFAPRO28
Device Problems Device Contamination with Body Fluid (2317); Material Integrity Problem (2978); Material Twisted/Bent (2981); Protective Measures Problem (3015)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/12/2024
Event Type  malfunction  
Manufacturer Narrative
Continuation of d10: product id: afapro28 product type: balloon catheter; product id: 106e2 product type: console.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that during a cryo ablation procedure, a system notice was received indicating that the safety system detected fluid in the catheter and stopped the injection.The coaxial umbilical cable without resolution.Another system notice was received indicating that there was a problem with the refrigerant port.Blood ingression into the coaxial umbilical cable and coaxial port was noted.The case was aborted.The patient was not under general anesthesia.A field service visit took place at a later time and fluid was visible in the coaxial port.A system notice was also received indicating a mechanical component error.The vacuum pump and high pressure regulator (hpr) were replaced.The console was serviced as appropriate. no patient complications have been reported as a result of this event.
 
Manufacturer Narrative
Product event summary: the data file was received and analyzed.The failure data file contained failure records for the date of the event and showed persistent system notice 50005 (the safety system has detected fluid in the catheter and stopped the injection) on the reported date of the event.It also showed system notice 50024 (there is a problem with the refrigerant port) on the reported date of the event.In conclusion, the system notices were confirmed in the data files.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Manufacturer Narrative
Concomitant medical product: product id:203cx product type: accessory; product id:203cx product type: accessory.Product event summary: the afapro28 balloon catheter with lot number 20337 was returned and analyzed.External visual inspection of the balloon segment was carried out and showed blood/fluid inside the balloon.The catheter smart chip data was downloaded and reviewed.Data indicated the catheter was used for six applications on the reported event date.During functional testing, the console terminated the application and triggered system notice #50005 ¿indicating that the safety system detected fluid in the catheter and stopped the injection¿.During inspection of the handle segment, blood/liquid was observed inside the handle.Pressure testing and inspection of sub-components of the balloon, handle, and shaft segments was carried out.During inspection and pressure testing of the shaft segment, a guide wire lumen kink and breach was observed 0.4 and 0.9 inches proximal to the catheter tip.In conclusion, the reported visible blood was confirmed, and the balloon catheter failed the return product inspection due to a breach on the guide wire lumen and a kink/twist observed on the guide wire lumen.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCTIC FRONT ADVANCE PRO¿ CARDIAC CRYOABLATION CATHETER
Type of Device
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
MEDTRONIC CRYOCATH LP
9000 autoroute transcanadienne
pointe-claire,qc H9R 5 Z8
CA  H9R 5Z8
Manufacturer (Section G)
MEDTRONIC CRYOCATH LP
9000 autoroute transcanadienne
pointe-claire,qc H9R 5 Z8
CA   H9R 5Z8
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key18802422
MDR Text Key336999378
Report Number3002648230-2024-00064
Device Sequence Number1
Product Code OAE
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P100010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 04/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/28/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberAFAPRO28
Device Catalogue NumberAFAPRO28
Device Lot Number20337
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/21/2024
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/02/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/28/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-